Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bonfiglio

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Chemotherapy|June 16, 2001
Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa?G Bonfiglio
Minerva Medica|April 11, 1970
[Current problems concerning the care of alcoholics]G Bonfiglio
Chemotherapy|June 22, 2000
In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactamsG Bonfiglio, F Marchetti
The Journal of Antimicrobial Chemotherapy|September 1, 1993
Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinationsG Bonfiglio, D M Livermore
The Journal of Antimicrobial Chemotherapy|December 1, 1991
Effect of media composition on the susceptibility of Xanthomonas maltophilia to beta-lactam antibioticsG Bonfiglio, D M Livermore
Diagnostic Microbiology and Infectious Disease|July 1, 1994
Inoculum effects on Etests and agar dilution minimum inhibitory concentrations. Piperacillin and piperacillin-tazobactam against Staphylococcus aureusG Bonfiglio, D M Livermore
The Journal of Antimicrobial Chemotherapy|March 1, 1994
beta-Lactamase types amongst Staphylococcus aureus isolates in relation to susceptibility to beta-lactamase inhibitor combinationsG Bonfiglio, D M Livermore
Expert Opinion on Investigational Drugs|February 15, 2001
Novel streptogramin antibioticsG Bonfiglio, P M Furneri
The Journal of Antimicrobial Chemotherapy|January 1, 1994
Zinc ions and medium-dependent susceptibility to beta-lactams in Xanthomonas maltophiliaG Bonfiglio, D M Livermore
La Clinica Terapeutica|August 31, 1974
[Treatment of alcoholism with a new drug: tibamide]G Bonfiglio, S Falli, A Pacini
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Chemotherapy|June 16, 2001
Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa?G Bonfiglio
Minerva Medica|April 11, 1970
[Current problems concerning the care of alcoholics]G Bonfiglio
Chemotherapy|June 22, 2000
In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactamsG Bonfiglio, F Marchetti
The Journal of Antimicrobial Chemotherapy|September 1, 1993
Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinationsG Bonfiglio, D M Livermore
The Journal of Antimicrobial Chemotherapy|December 1, 1991
Effect of media composition on the susceptibility of Xanthomonas maltophilia to beta-lactam antibioticsG Bonfiglio, D M Livermore
Diagnostic Microbiology and Infectious Disease|July 1, 1994
Inoculum effects on Etests and agar dilution minimum inhibitory concentrations. Piperacillin and piperacillin-tazobactam against Staphylococcus aureusG Bonfiglio, D M Livermore
The Journal of Antimicrobial Chemotherapy|March 1, 1994
beta-Lactamase types amongst Staphylococcus aureus isolates in relation to susceptibility to beta-lactamase inhibitor combinationsG Bonfiglio, D M Livermore
Expert Opinion on Investigational Drugs|February 15, 2001
Novel streptogramin antibioticsG Bonfiglio, P M Furneri
The Journal of Antimicrobial Chemotherapy|January 1, 1994
Zinc ions and medium-dependent susceptibility to beta-lactams in Xanthomonas maltophiliaG Bonfiglio, D M Livermore
La Clinica Terapeutica|August 31, 1974
[Treatment of alcoholism with a new drug: tibamide]G Bonfiglio, S Falli, A Pacini
Pageof 5